Talimogene Laherparepvec Intralesional Regimen
specificA regimen consisting of intralesional talimogene laherparepvec that may be used in the treatment of cutaneous melanoma and Merkel cell carcinoma.
Top Centers for Talimogene Laherparepvec Intralesional Regimen
Ranked by research excellence score (trials · grants · publications). Methodology →
No centers currently specializing in this cancer type.
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →